Cargando…
Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance
Although new developments of surgery, chemotherapy, radiotherapy, and immunotherapy treatments for cancer have improved patient survival, the emergence of chemoresistance in cancer has significant impacts on treatment effects. The development of chemoresistance involves several polygenic, progressiv...
Autores principales: | Li, Guo-Hua, Qu, Qiang, Qi, Ting-Ting, Teng, Xin-Qi, Zhu, Hai-Hong, Wang, Jiao-Jiao, Lu, Qiong, Qu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132395/ https://www.ncbi.nlm.nih.gov/pubmed/34011395 http://dx.doi.org/10.1186/s13046-021-01974-y |
Ejemplares similares
-
Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
por: Tang, Zhen-Chu, et al.
Publicado: (2023) -
Corrigendum: Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
por: Tang, Zhen-Chu, et al.
Publicado: (2023) -
The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors
por: Li, Xiang-Ping, et al.
Publicado: (2023) -
Clinical Analysis of Metagenomic Next-Generation Sequencing Confirmed Chlamydia psittaci Pneumonia: A Case Series and Literature Review
por: Teng, Xin-Qi, et al.
Publicado: (2021) -
A Comparative Study of the Microbiological Efficacy of Polymyxin B on Different Carbapenem-Resistant Gram-Negative Bacteria Infections
por: Lu, Qiong, et al.
Publicado: (2021)